Treatment of Myiasis (Maggot Infestation)
For myiasis, administer the "Triple Therapy" regimen: oral ivermectin 12 mg once daily for 3 days, albendazole 400 mg twice daily for 3 days, and clindamycin 300 mg three times daily for 5 days, combined with mechanical removal and wound care.
Rationale for Triple Therapy
The evidence strongly supports this systemic antiparasitic approach, particularly for malignant wound myiasis. In a prospective study of 25 advanced head-and-neck cancer patients, this regimen achieved 73% reduction in maggot burden by Day 1 and over 92% reduction by Day 3 1. This represents the most specific and evidence-based protocol for myiasis management in the medical literature.
Treatment Algorithm
Immediate Management (Day 0-1)
Start Triple Therapy immediately:
- Ivermectin 12 mg PO once daily × 3 days
- Albendazole 400 mg PO twice daily × 3 days
- Clindamycin 300 mg PO three times daily × 5 days (extended to cover secondary bacterial infection)
Mechanical removal: Manual extraction of visible larvae using forceps and irrigation with normal saline
Topical wound care: Apply turpentine oil dressing or petroleum gauze occlusive dressing 1, 2
Days 1-7 Monitoring
- Assess maggot burden daily—expect dramatic reduction within 24-72 hours
- Continue wound irrigation and dressing changes
- Monitor for complications: bleeding, tissue destruction, orbital involvement (if near facial structures) 3
Pain Management
- Administer oral morphine titrated to pain scores—mean dose around 100 mg/day may be required in severe cases 1
- Pain typically improves significantly as larval burden decreases
Important Clinical Considerations
Why This Specific Regimen Works
- Ivermectin: Paralyzes and kills larvae through GABA-mediated neurotoxicity
- Albendazole: Provides additional antiparasitic coverage and prevents re-infestation
- Clindamycin: Treats inevitable secondary bacterial infection in necrotic tissue 1, 4
Common Pitfalls to Avoid
- Do not rely on mechanical removal alone—systemic therapy is essential for complete eradication, especially in deep or inaccessible wounds
- Do not delay treatment—myiasis can rapidly progress to life-threatening complications including sepsis, hemorrhage, and organ invasion if near vital structures 5
- Avoid using only topical agents—while turpentine oil helps, systemic antiparasitics are required for definitive treatment
Special Populations
- Advanced malignancy patients: This is the most common population affected, particularly with head-neck cancers and fungating wounds 1, 4, 2
- Immunocompromised/debilitated patients: Require more aggressive monitoring for complications
- Nasal/orbital myiasis: May need ENT consultation if orbital cellulitis develops; ivermectin remains effective 3
Expected Outcomes
- Day 1: 70-75% reduction in larvae
- Day 3: >90% reduction in larvae
- Day 5-7: Complete resolution with significant improvement in pain, odor, and wound appearance 1
Side Effects
The triple therapy regimen produces self-limiting side effects that do not require treatment discontinuation 1. Continue the full course despite minor adverse effects.
Psychosocial Support
Myiasis causes profound psychological distress and social isolation due to visible infestation, odor, and tissue destruction. Provide comprehensive caregiver education and emotional support as integral components of care 4, 2.